Looking ugly again today. Their achilles heel has been exposed - the impossibility of growing the business to an acceptable ROA.Rising costs and the inability to raise fees in the current environment will squeeze the profit margin even more.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game